Molecular Clues Help Refine Kinase Inhibitor Strategy for GI


Robert G. Maki, M.D., Ph.D., Memorial Sloan-Kettering Cancer Centerhttp://... -- In the post-imatinib (Gleevec) era, treatment of gastrointestinal stromal tumors has shifted from serial surgeries to refinement of kinase inhibitor dosing, according to this presentation from the ASCO-GI symposium here.







Channel: Education
Uploaded: February 1, 2008 at 9:07 am
Author: MedPageToday

Length: 00:10:56
Rating: 5.00
Views: 290

Tags: medicine health

Embed Code:


Video Comments:
No Comment
 

Privacy Policy Cancer Video | Treatment Survival & Education Copyright © 2007 All Rights Reserved.